The latest Business updates from the science industry
by Heather Hobbs Specialist to lead North American Operations
Nick Moore, PhD has been appointed to head up business development in North America for drug discovery development and compound services management company BioAscent.
An internationally recognised specialist Dr Moore has directed a range of drug discovery programs spanning multiple therapeutic indications, including leading the preclinical development of the $5 billion blockbuster Zyprexa (olanzapine) for Eli Lilli. He has held senior roles in the US and the UK, with both in-house and contract research organisation experience, most recently including Charles River Discovery Services.
“Working with customers varying from the smallest academic spin- out to large pharma, and being able to offer customised services to meet their exact requirements was a real draw for me,” said Dr Moore. “BioAscent’s capabilities in drug discovery and compound management are an especially good fi t with VC-funded biotechs, because we offer a rare mix of leading infrastructure and scientifi c
excellence. We can really contribute scientifi cally to their project teams, and also provide compound management expertise to ensure that the right compounds are shipped to the right place, at the right time, in the right format - and in the most cost-effective and trackable way.”
Paul Smith, BioAscent’s CEO said: “Having state-of-the-art facilities and a broad range of services are really important to BioAscent’s offering, however it’s the excellence of our people that makes the real difference to our customers. Nick’s track record in drug discovery and development, including being a recipient of the prestigious ‘Society for Medicines Research Award for Drug Discovery’, is a clear demonstration of our policy of hiring the best people and we look forward to further expanding our customer base in North America.”
52743pr@reply-direct.com Dr Nick Moore
Supporting Mental Health Charities during Lockdown
deadly as the virus itself. We wanted to help out in our own small way and chose the Campaign Against Living Miserably (CALM) in the UK and the American Foundation for Suicide Prevention (AFSP) to receive our support.”
Ziath will donate the equivalent of £5000 to both charities.
The CEO of CALM, Simon Gunning, said: “We’re grateful for Ziath’s generous donation to the CALM cause. Since lockdown we’ve experienced a huge surge in demand for our helpline, and the demand continues to be unprecedented. That means, right now, we’re taking a record number of calls from people who are struggling with a variety of mental health issues. Ziath’s donation means we’ll be able to answer an additional 600 potentially lifesaving calls and webchats, continuing to support those who need us most.”
The Regional Director of the American Foundation for Suicide Prevention, Jessica van der Stad, said: “The AFSP is honoured to partner with Ziath LLC. Now is a critically important time to raise awareness of mental health and increase funds for lifesaving suicide prevention efforts. We could not do this without Ziath’s initiative and involvement from their industry partners. We are in this together and together we can save lives.”
Sample management solutions company Ziath, a manufacturer of scanners for reading 2D barcodes on sample tubes, are making signifi cant donations to two highly acclaimed mental health charities – one in the UK and one in the US - to support their work helping those affected by the stress of living through the uncertainty and restrictions imposed during the lockdown period.
Neil Benn, Managing Director of Ziath commented: “Our small company has been working fl at out to build tube scanners for the UN/ IAEA Covid-19 screening programme around the World. Although we are all tired and working long hours to meet the demand, we are still mindful of the many thousands of people who are stuck inside their house, or apartment with no prospect of social contact, going to work, or relaxing in a bar or restaurant. The stress caused by the current lockdown affects us all, it can be an unseen killer just as
Ziath’s Commercial Director, Steve Knight, urged other companies who are still working during the pandemic to consider doing something similar. “Mental health issues during lockdown are increasing across the population. With no immediate end to the crisis in sight, we’d urge other businesses who can afford it to consider supporting these vitally important charities and the work they do.”
CALM operate a free UK wide helpline and webchat which is available from 5pm - midnight 365 days a year on 0800 58 58 58 and via
www.thecalmzone.net. In the USA, you can call 800-273- 8255 or text TALK to 741741 to reach help at the AFSP or visit their website at
www.afsp.org/mental-health-and-covi-19.
More information online:
ilmt.co/PL/EpXG 52502pr@reply-direct.com
Change of Company Name and Rebranding of SciLabware Ltd
On 6th July 2020, SciLabware Ltd, with headquarters in Stoke-on- Trent, changed its name to DWK Life Sciences Ltd.
Since 2011 SciLabware has been part of the DWK Life Sciences group, a leading global manufacturer of premium scientifi c labware and container solutions for a wide range of life science, technical and packaging applications. As a customer focused organisation DWK Life Sciences concentrates on a continuous harmonisation towards ‘one face to the customer’. In this respect, the company are now taking the next step to align SciLabware with the DWK Life Sciences Group. In the future SciLabware Ltd. will appear under the new company name DWK Life Sciences Ltd. This offi cial name change also entails a change of the previous company branding, and will now uniformly act as DWK Life Sciences globally.
“By combining all sales and marketing activities in Europe, we are reducing complexity and providing more clarity to our customers,” said Michael Merz, Managing Director of DWK Life Sciences GmbH. “Our customers will benefi t from this positive development, as they now have one contact person for all product brands managed in Europe and being maximally taken care of.”
Furthermore, SciLabware’s web domain and e-mail addresses will change as a result of the name change. In parallel, the DWK company logo and branding will be implemented on all product and company-related materials.
More information online:
ilmt.co/PL/m2Y6 and
ilmt.co/PL/BeqQ 52692pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
